Publication | Closed Access
Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ
96
Citations
26
References
2008
Year
The CABERNET trial demonstrates that CAS with NexStent and FilterWire is noninferior to (equivalent or better than) traditional CEA at 1 year in high-surgical-risk patients based on historical controls.
| Year | Citations | |
|---|---|---|
Page 1
Page 1